Patent details

EP3470063 Title: PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES

Basic Information

Publication number:
EP3470063
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP181925041
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE MALADIES INDUITES PAR CFTR
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON CFTR-VERMITTELTEN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
01/11/2013
Grant date:
01/01/2025
EP Publication Date:
17/04/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/01/2025
EP B1 Publication Date:
01/01/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
01/11/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/12/2024
 
 

Name:
Vertex Pharmaceuticals Incorporated
Address:
50 Northern Avenue, Boston, MA 02210, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
02/01/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
MOORE, Michael, Douglas
Address:
United States (US)

2

Name:
VERWIJS, Marinus, Jacobus
Address:
United States (US)

3

Name:
KARKARE, Radhika
Address:
United States (US)

Priority

1

Priority Number:
201261721622 P
Priority Date:
02/11/2012
Priority Country:
United States (US)

2

Priority Number:
201261728328 P
Priority Date:
20/11/2012
Priority Country:
United States (US)

3

Priority Number:
201361770668 P
Priority Date:
28/02/2013
Priority Country:
United States (US)

4

Priority Number:
201361824005 P
Priority Date:
16/05/2013
Priority Country:
United States (US)

5

Priority Number:
201361840668 P
Priority Date:
28/06/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61P 11/00; A61K 9/20; A61K 45/06; A61K 31/443; A61K 31/47;

Publication

European Patent Bulletin

1

Issue number:
202501
Publication date:
01/01/2025
Description:
Grant (B1)

2

Issue number:
202506
Publication date:
05/02/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
02/01/2025 Power Of Attorney 1
03/01/2025 Outgoing Correspondence 1